Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 2/20 | 0.67 |
| ▸ | GABRD | O14764 | 2/20 | 0.67 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.67 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.67 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.67 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.67 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.67 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.67 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.67 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.67 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.67 |
| ▸ | GABRE | P78334 | 2/20 | 0.67 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.67 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.67 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.67 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 5/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1881592 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL31158246 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1876354 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1879457 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1882607 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL244824 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1885384 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1875146 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1882596 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1880221 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 314 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4700064-A1 | AMORPHOUS COPOLYAMIDES OBTAINED FROM 2,5-FURANDICARBOXYLIC ACID | ARKEMA FRANCE (FR) | 2026-02-25 | — | — | EP | claimed |
| US-12378411-B2 | Use of a reinforced thermoplastic composition | ARKEMA FRANCE (FR) | 2025-08-05 | — | — | US | claimed |
| US-20230060165-A1 | USE OF A REINFORCED THERMOPLASTIC COMPOSITION | ARKEMA FRANCE (FR) | 2023-03-02 | — | — | US | claimed |
| US-20230057798-A1 | USE OF A REINFORCED THERMOPLASTIC COMPOSITION | ARKEMA FRANCE (FR) | 2023-02-23 | — | — | US | claimed |
| US-20210230194-A1 | SILOXANE DERIVATIVES OF AMINO ACIDS HAVING SURFACE-ACTIVE PROPERTIES | TRUIST BANK, AS ADMINISTRATIVE AGENT | 2021-07-29 | — | — | US | claimed |
| EP-2310439-B2 | SEMI-AROMATIC COPOLYAMIDE AND METHOD FOR THE PREPARATION THEREOF | ARKEMA FRANCE (FR) | 2021-03-03 | — | — | EP | claimed |
| WO-2020260479-A1 | USE OF A REINFORCED THERMOPLASTIC COMPOSITION | ARKEMA FRANCE (FR) | 2020-12-30 | — | — | WO | claimed |
| WO-2020258266-A1 | USE OF A REINFORCED THERMOPLASTIC COMPOSITION | ARKEMA FRANCE (FR) | 2020-12-30 | — | — | WO | claimed |
| EP-3672935-A1 | PROCESS FOR PURIFYING LONG CHAIN AMINO ACIDS | Vitaworks IP, LLC (US) | 2020-07-01 | — | — | EP | claimed |
| CN-111032623-A | Process for purifying long-chain amino acid | 维生源知识产权有限责任公司 | 2020-04-17 | — | — | CN | claimed |
| EP-3006485-B1 | SEMI-AROMATIC POLYAMIDE WITH CHAIN TERMINATION | ARKEMA FRANCE (FR) | 2019-10-09 | — | — | EP | claimed |
| US-10239823-B2 | Process for purifying long chain amino acids | VITAWORKS IP, LLC | 2019-03-26 | — | — | US | claimed |
| WO-2019040177-A1 | PROCESS FOR PURIFYING LONG CHAIN AMINO ACIDS | VITAWORKS IP, LLC (US) | 2019-02-28 | — | — | WO | claimed |
| US-20170073470-A1 | SEMI-AROMATIC COPOLYAMIDE AND PROCESS FOR PREPARING SAME | ARKEMA FRANCE (FR) | 2017-03-16 | — | — | US | claimed |
| WO-2015134769-A1 | RENEWABLY DERIVED ALDEHYDES AND METHODS OF MAKING AND USING THE SAME | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2015-09-11 | — | — | WO | claimed |
| CN-102666652-B | Semiaromatic polyamide, process for preparing same, composition comprising such a polyamide and uses thereof | ARKEMA FRANCE | 2015-03-25 | — | — | CN | claimed |
| EP-2310439-B1 | SEMI-AROMATIC COPOLYAMIDE AND METHOD FOR THE PREPARATION THEREOF | ARKEMA FRANCE (FR) | 2012-02-08 | — | — | EP | claimed |
| US-20110195215-A1 | SEMI-AROMATIC COPOLYAMIDE AND PROCESS FOR PREPARING SAME | ARKEMA FRANCE (FR) | 2011-08-11 | — | — | US | claimed |
| US-12606705-B2 | Transparent molding compositions based on polyamides, impact modifier and short glass fibers and uses thereof | ARKEMA FRANCE (FR) | 2026-04-21 | — | — | US | disclosed |
| EP-0107948-A1 | Leather with fluorochemical finish | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1984-05-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606705-B2 | Transparent molding compositions based on polyamides, impact modifier and short glass fibers and uses thereof | CUTA, TERB1, SMCHD1 | GABRP 2282/4885GABRD 3637/4885GABRA1 1897/4885 |
| US-20210230194-A1 | SILOXANE DERIVATIVES OF AMINO ACIDS HAVING SURFACE-ACTIVE PROPERTIES | BCAT1, PCMT1, LTN1 | GABRP 635/4885GABRD 1007/4885GABRA1 1186/4885 |
| US-10239823-B2 | Process for purifying long chain amino acids | BCAT1, SLC43A1, BCAT2 | GABRP 223/4885GABRD 368/4885GABRA1 463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.